Who are Indigotindisulfonate sodium 0.8%'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Fluorescite, Spy Agent Green Kit, Fluorescéine Sodique Faure.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/indigotindisulfonate-sodium-0-8.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Indigotindisulfonate sodium 0.8% — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Indigotindisulfonate sodium 0.8% (Indigotindisulfonate sodium 0.8%) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Diagnostic dye. Area: Urology.

marketed Diagnostic dye Urology Small molecule Live · refreshed every 30 min

Target snapshot

Indigotindisulfonate sodium 0.8% (Indigotindisulfonate sodium 0.8%) — Prove pharm. Indigotindisulfonate sodium is a vital dye that is used diagnostically to visualize the urinary tract and bladder during cystoscopy and other urological procedures.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Indigotindisulfonate sodium 0.8% TARGET	Indigotindisulfonate sodium 0.8%	Prove pharm	marketed	Diagnostic dye
Fluorescite	FLUORESCEIN	Novartis	marketed	Diagnostic Dye	Cytochrome P450 2C19	2020-01-01
Spy Agent Green Kit	INDOCYANINE GREEN	Renew Pharms	marketed	Diagnostic Dye		1959-01-01
Fluorescéine Sodique Faure	Fluorescéine Sodique Faure	Rennes University Hospital	phase 3	Fluorescent diagnostic dye

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2028-06-04 — Spy Agent Green Kit · 8185176 · Method of Use · US
2029-02-11 — Spy Agent Green Kit · 8647605 · Method of Use · US
2029-04-09 — Spy Agent Green Kit · 8406860 · Method of Use · US
2035-08-04 — Spy Agent Green Kit · 10631746 · Formulation · US
2039-07-14 — Spy Agent Green Kit · 11712320 · Formulation · US

Sponsor landscape (Diagnostic dye class)

Prove pharm · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Indigotindisulfonate sodium 0.8% — Competitive Intelligence Brief. https://druglandscape.com/ci/indigotindisulfonate-sodium-0-8. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab